Minnesota medical device and biotech companies won about $24 million in tax credits and grants from the Qualified Therapeutic Discovery program. The $1 billion initiative born from federal healthcare reform law seeks to boost companies working on therapies that save money.
MedCity News first reported the seeds of Minnesota’s haul when it learned Tuesday that Pursuit Vascular Inc. was a grant winner — $244,000 over two years.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
All in all, more than 80 Minnesota companies received money, most of them opting for grants with only three companies choosing tax credits.
The winners ranged from the usual suspects (Orasi Medical, EnteroMedics and AUM Cardiovascular) to the less familiar (Antares Medical, Tumor Biology Investment Group, and GeneSegues Inc.).
For the full list of grant winners, click here, and for tax credit recipients, click here.
